Aptamer Group plc (APTA.L)

0.6750 0.0000 (0.00%) At close: 03:31PM BST

Aptamer Group plc

Windmill House
Innovation Way
York YO10 5BR
United Kingdom
44 19 0421 7404
https://aptamergroup.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 37

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Arron Craig Tolley	Chief Technical Officer & Director	246k	N/A	1977
Dr. David Bunka	Chief Scientific Officer, Member of the Scientific Advisory Board & Executive Director	202k	N/A	1978
Mr. Stephen Hull	Executive Chairman	N/A	N/A	1953
Andrew Rapson	CFO & Company Secretary	N/A	N/A	N/A
Mr. Alastair Fleming	Chief Operating Officer	N/A	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

Aptamer Group plc provides binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, and internationally. The company offers Optimer platform that enables the discovery and development of oligonucleotide binders; custom development services for oligonucleotide-based aptamer and Optimer binders; solutions to bioprocessing, diagnostic, and pharmaceutical scientists; and contract research services in the field of therapeutics. It serves pharma companies, diagnostic development companies, and research institutes. Aptamer Group plc was founded in 2008 and is headquartered in York, the United Kingdom.

Corporate Governance

Aptamer Group plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.